Robert H. Dworkin is Professor of Anesthesiology, Neurology, and Psychiatry, Professor in the Center for Human Experimental Therapeutics, and Director of the Anesthesiology Clinical Research Center at the University of Rochester School of Medicine and Dentistry. He received his B.A. in 1971 from the University of Pennsylvania and his Ph.D. in 1977 from Harvard University.

Dr. Dworkin is Director of the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership with the U.S. Food and Drug Administration (FDA); a Special Government Employee of the FDA Center for Drug Evaluation and Research; and Co-Chair of the Acute to Chronic Pain Transition Work Group of the U.S. Federal Pain Research Strategy. He previously served as a consultant to and member of the FDA Anesthetic and Life Support Drugs Advisory Committee and as a member of the U.S. Centers for Disease Control and Prevention Herpes Zoster Working Group. He is currently an Associate Editor of Pain, and a member of the Editorial Boards of Journal of Pain, Canadian Journal of Pain, and Current Pain and Headache Reports. Dr. Dworkin received the American Pain Society’s Wilbert E. Fordyce Clinical Investigator Award in 2005 and John and Emma Bonica Public Service Award in 2014, the Eastern Pain Association’s John J. Bonica Award in 2011, and the American Academy of Neurology’s Mitchell B. Max Award for Neuropathic Pain in 2015.

Dr. Dworkin has authored over 300 journal publications and book chapters, and has served as a consultant to over 150 pharmaceutical and device companies in the development and evaluation of analgesic and antiviral treatments. As Director of the Anesthesiology Clinical Research Center, he has been the principal investigator for a large number of clinical trials of analgesic treatments.